Surgery Doctors in Kennewick, WA Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Mr. Steven J Kincaid, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 216 W 10th Ave, Ste 206, Kennewick, WA 99336 Phone: 509-585-5320    Fax: 509-585-5329

Dr. Janel Burgdorff, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 911 S Washington St, Suite B, Kennewick, WA 99336 Phone: 509-586-2828    Fax: 509-586-2525

Ernesto G Dizon Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3730 Plaza Way Fl 5, Kennewick, WA 99338 Phone: 509-221-6550    Fax: 509-221-6511

Jozef William Pavnica, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3730 Plaza Way Fl 5, Kennewick, WA 99338 Phone: 509-221-6550    Fax: 509-221-6511

Mr. Leandro Tuazon Cabanilla, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3730 Plaza Way, Kennewick, WA 99338 Phone: 509-221-6550    Fax: 509-221-6230

Jillian Lee Thayer, MD Surgery Medicare: Medicare Enrolled Practice Location: 3730 Plaza Way Fl 5, Kennewick, WA 99338 Phone: 267-441-4583

James Michael Scully, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 216 W 10th Ave, Suite 202, Kennewick, WA 99336 Phone: 509-585-5954    Fax: 509-586-5869

News Archive

Fluidigm, GIS announce establishment of first single-cell genomics research center in Asia

The Genome Institute of Singapore (GIS), an institute under the umbrella of the Agency for Science, Technology and Research, and Fluidigm Corporation today announced the establishment of the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.

Ovarian cancer patients survive longer with BRCA2 mutation in tumors

Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type, according to a study in the October 12 issue of JAMA.

New study finds increase in use of adjuvant systemic therapy for gastrointestinal stromal tumors

A new study finds that the use of adjuvant systemic therapy for localized gastrointestinal stromal tumors (GISTs ) has significantly increased over time and that patients treated with the therapy have better survival than those treated with surgery alone.

SCT, Thermo Fisher Scientific collaborate to advance development of cardiac disease models

Stem Cell Theranostics announced today that they have successfully completed a research collaboration with Thermo Fisher Scientific focused on advancing the development of cardiac disease models derived from induced pluripotent stem cells using Thermo Fisher Scientific's suite of work flow reagents and SCT's patient biobank and proprietary disease modeling methods.

Finding opens door to early identification of individuals at risk for delirium complications

Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. This finding opens the door to easy, early identification of individuals at risk for longer delirium duration and higher delirium severity and could potentially lead to new treatments of this brain failure for which drugs have been shown to be largely ineffective.

Read more Medical News

› Verified 9 days ago